Infantile Myofibromatosis
1 clinical trials · Condition
◉ Watch Infantile Myofibromatosis
| Record | Firm | Date |
|---|---|---|
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors (NCT03899792) | Eli Lilly and Company | 2019-06-13 |
Track Infantile Myofibromatosis automatically
Every clearance here is in the API, with alerts when new ones post.